Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study

By sjmartinez • July 27, 2024

Song JJ, Jackson NJ, Shang H, Honda HM, Boulier K. Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study. J Cardiovasc Pharmacol Ther. 2024 Jan-Dec;29:10742484241256271. doi: 10.1177/10742484241256271. PMID: 39053441.

Tags: Anticoagulation, atrial fibrillation, Cardiology/Epi, Cirrhosis, Fellow, General Internal Medicine, Hematology/Oncology, Publications, Resident, safety outcomes

Hepatic lipid metabolism is altered in Ubiad1+/- mice of both sexes

Higa R, Pourteymour S, Kolan PS, Dankel SN, Fernø J, Mellgren G, Pan C, Seldin MM, Lusis AJ, Drevon CA, Dalen KT, Norheim FA. Hepatic[...]

Sex-Divergent Blood Pressure Associations With Multiorgan System Metabolic Stress

Kwan AC, Wang M, Ji H, Claggett B, Ouyang D, Trivedi H, Sharma S, Shyy J, Velazquez A, Ebinger JE, Cheng S. Sex-Divergent Blood Pressure[...]

Association of depression and anxiety with coronary artery plaque among asymptomatic adults: The Miami Heart study (MiHeart) at Baptist Health South Florida

Bafna T, Dzaye O, Dardari Z, Cainzos-Achirica M, Blankstein R, Feldman T, Budoff MJ, Fialkow J, Nasir K, Blaha MJ. Association of depression and anxiety[...]